Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant.

We identified impaired BMP signalling as a hallmark of early vascular disease in the injured neonatal lung while outlining its promising potential as a future biomarker or therapeutic target in this growing, high-risk patient population.